Cardio Diagnostics Holdings Inc.
CDIO • NASDAQ
Cardio Diagnostics Holdings Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Meeshanthini V. Dogan, with a market cap of $5.8M.
CEOMeeshanthini V. Dogan
Next Earnings
Upcoming earnings announcement for Cardio Diagnostics Holdings Inc.
Date
Thursday, May 14, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for Cardio Diagnostics Holdings Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | Q4 2025 | -$0.80 | — | $3.6K | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.98Est: -$1.80 | +45.6% | $2.9KEst: $150.0K | -98.1% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.97Est: -$1.80 | +46.1% | $7.5KEst: $75.0K | -90.0% | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.97Est: -$0.06 | -1516.7% | $940.0Est: $50.0K | -98.1% | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.01Est: -$0.06 | +83.3% | $4.5KEst: $25.0K | -82.0% | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.06Est: -$0.10 | +40.0% | $6.6KEst: $100.0K | -93.4% | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.06Est: -$0.11 | +45.5% | $7.9KEst: $110.0K | -92.8% | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.20Est: -$0.09 | -122.2% | $15.9KEst: $1.0M | -98.4% | 10-Q |
| Apr 1, 2024 | Q4 2023 | $0.00Est: -$0.13 | +100.0% | $5.3KEst: $250.0K | -97.9% | — |
| Nov 13, 2023 | Q3 2023 | -$0.16Est: -$0.27 | +40.7% | $10.0KEst: $120.0K | -91.6% | — |
| Aug 14, 2023 | Q2 2023 | -$0.35Est: -$0.18 | -94.4% | $1.7K | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.11Est: -$0.18 | +38.9% | -Est: $60.0K | -100.0% | 10-Q |